LCTX - Lineage Cell Therapeutics, Inc.

QQQ $ 442.84 $ 1.02 (0.23 %)

DIA $ 394.52 $ -0.72 (-0.18 %)

SPY $ 520.61 $ 0.07 (0.01 %)

TLT $ 90.36 $ 0.23 (0.26 %)

GLD $ 216.28 $ -2.45 (-1.12 %)

Previous Close

$ 1.09

Open

$ 1.12

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.08 - $ 1.14

52 Week Range

$ 0.84 - $ 1.61

Volume

849,773

Average Volume

Market Cap

199.37M

Beta (5Y Monthly)

$ 1.01

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-07-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-09-2023	12-31-2022	10-K
7	11-10-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-10-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-11-2021	12-31-2020	10-K
15	11-04-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	03-12-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	03-14-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-02-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-15-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-Q
29	05-10-2017	03-31-2017	10-Q
30	03-16-2017	12-31-2016	10-K
31	11-04-2016	09-30-2016	10-Q
32	08-09-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-15-2016	12-31-2015	10-K
35	11-09-2015	09-30-2015	10-Q
36	08-10-2015	06-30-2015	10-Q
37	05-08-2015	03-31-2015	10-Q
38	03-11-2015	12-31-2014	10-K
39	11-07-2014	09-30-2014	10-Q
40	08-11-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Lineage Cell Therapeutics Q1 2024 GAAP EPS...
05/09/2024 21:03:38

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. ...

HC Wainwright & Co. Reiterates Buy on Line...
05/06/2024 14:40:33

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lineage Cell Therapeutics (AMEX:LCTX) with a Buy and maintains $...

Lineage Cell Therapeutics Announces OpRege...
05/06/2024 12:04:47

BCVA gains of +5.5 letters at 24 months in Cohort 4 patients (n=10)BCVA gains of +7.4 letters among Cohort 4 patients with exte...

Lineage Cell Therapeutics Inc May Offer An...
03/22/2024 20:36:22

- SEC Filing

Lineage Cell Therapeutics Entered Into Sal...
03/22/2024 20:29:55

-SEC Filing

Lineage Cell Therapeutics, Inc. Announces ...
03/13/2024 12:13:02

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ce...

Lineage Cell Therapeutics Announces OpRege...
03/11/2024 12:06:48

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ce...

HC Wainwright & Co. Reiterates Buy on Line...
03/08/2024 11:12:25

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lineage Cell Therapeutics (AMEX:LCTX) with a Buy and maintains $...

Lineage Cell Therapeutics: Q4 Earnings Ins...
03/07/2024 21:05:17

Lineage Cell Therapeutics Q4 2023 GAAP EPS...
03/07/2024 21:02:22

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.030) per share which beat the analyst consensus estimate...

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

A Preview Of Lineage Cell Therapeutics's E...
03/06/2024 18:02:17

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
02/14/2024 13:05:52

HC Wainwright & Co. Reiterates Buy on Line...
02/13/2024 17:38:56

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lineage Cell Therapeutics (AMEX:LCTX) with a Buy and maintains $...

Lineage Announces FDA Clearance Of IND Ame...
02/13/2024 13:06:29

Lineage Cell Therapeutics Announces $14M M...
02/06/2024 14:17:26

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ce...

Cantor Fitzgerald Reiterates Overweight on...
02/05/2024 14:27:55

Cantor Fitzgerald analyst Kristen Kluska reiterates Lineage Cell Therapeutics (AMEX:LCTX) with a Overweight and maintains $6...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
02/01/2024 21:31:08

Lineage Cell Therapeutics, Inc. Announces ...
01/16/2024 13:23:00

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ce...

lineage-cell-therapeutics-longeveron-and-2-other-stocks-under-2-insiders-are-buying

Lineage Cell Therapeutics, Longeveron And ...
01/03/2024 12:11:46

The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their con...